 |
인쇄하기
취소
|
National health insurance to cover antiarrhythmic drug
The Ministry of Health and Welfare said Tuesday that Sanofi-Aventis’s antiarrhythmic drug Multaq (ronedarone) will be covered by national health insurance from May 1. The insurance coverage of Bristol-Myers Squibb/Pfizer’s Eliquis (apixaban) will be expanded, the ministry said.
Under the revised guideline, the use of Multaq is recommended as an alternative to amidarone for the treatment of a...
Under the revised guideline, the use of Multaq is recommended as an alternative to amidarone for the treatment of a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.